Healthcare Sales & Marketing Network News: CARDIOsphere

Searching News Database: CARDIOsphere

HSMN NewsFeed - 29 Nov 2017
Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Oct 2017
Capricor Therapeutics Presents Positive Six-Month Results in Duchenne Muscular Dystrophy at World Muscle Society International Congress
Regenerative Medicine

HSMN NewsFeed - 18 Jul 2017
Capricor Receives Rare Pediatric Disease Designation from FDA for CAP-1002 for Patients with Duchenne Muscular Dystrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 12 May 2017
Capricor Therapeutics Provides Update on ALLSTAR Trial
Regenerative Medicine Cardiology

HSMN NewsFeed - 17 Feb 2017
Capricor Therapeutics Provides Update on Natriuretic Peptide Program
Biopharmaceuticals

HSMN NewsFeed - 9 Jul 2012
Capricor Announces FDA Approval To Initiate ALLSTAR Trial of Allogeneic Stem Cell Therapy In Patients Following Heart Attack
Regenerative Medicine Cardiology FDA

HSMN NewsFeed - 17 Dec 2010
Cardiac Stem-Cell Pioneer Capricor Raises nearly $2 Million from Broadview Ventures, Private Investors
Regenerative Medicine Cardiology Venture Capital

HSMN NewsFeed - 6 Feb 2008
POINT Biomedical Corp. First Tranche of $50 Million in Equity Financing
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 12 Mar 2007
Thomas L. Feldman Joins POINT Biomedical as Chief Executive Officer
Biopharmaceuticals Cardiology Personnel

Return to NewsFeed

Additional items found! 4

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 4 additional stories matching:
CARDIOsphere
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.